Wells Fargo
IGMS

Wells Fargo’s IGM Biosciences IGMS Stock Holding History

Wells Fargo’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,100
Closed -$297K – 7103
2022
Q1 		$297K Buy
+11,100
New +$207K ﹤0.01% 4757

Other funds holding IGMS

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo's IGMS Position: Q3 2025 in Review

Wells Fargo sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 524 shares — an estimated $587 sold.

Wells Fargo first reported a position in IGMS in Q4 2019 and held it in 23 quarters. The position peaked at $1.91M in Q4 2020. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

  • Wells Fargo reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 524 IGM Biosciences shares in Q3 2025, an estimated $587.
  • Wells Fargo first reported a position in IGM Biosciences in Q4 2019 and held it in 23 quarters.
  • Wells Fargo's IGM Biosciences position peaked at $1.91M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.